Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome
NCT02052908
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
81
Enrollment
NIH
Sponsor class
Conditions
Lynch Syndrome
Interventions
OTHER:
Laboratory Biomarker Analysis
DRUG:
Naproxen
OTHER:
Placebo Administration
Sponsor
National Cancer Institute (NCI)